TABLE 2

Association Between Sex, Uropathogen Type, and Etiology of Neurogenic Bladder and Pyuria

Predictors	Cultures ≥10 000 CFU/mL		Cultures ≥100 000 CFU/mL
Predictors	Odds of Pyuria	95% CI	Odds of Pyuria	95% CI
Sex
Female	Reference	—	Reference	—
Male	1.69^a	(1.32–2.16)^a	1.70^a	(1.29–2.26)^a
Uropathogen
E coli	Reference	—	Reference	—
P aeruginosa	1.00	(0.63–1.61)	0.86	(0.48–1.59)
Staphylococcus saprophyticus	0.93	(0.13–18.60)	^b	^b
Enterococcus species	0.66^a	(0.47–0.91)^a	0.44^a	(0.30–0.64)^a
Klebsiella species	0.95	(0.67–1.36)	0.81	(0.54–1.20)
Proteus species	1.74	(0.93–3.56)	2.16^a	(1.05–5.03)^a
Enterobacter species	1.39	(0.77–2.66)	0.94	(0.53–1.73)
Other	0.86	(0.63–1.17)	0.83	(0.58–1.19)
Etiology of neurogenic bladder
Myelomeningocele	Reference	—	Reference	—
Anorectal malformation	0.94	(0.63–1.43)	1.16	(0.72–1.92)
Tethered cord	1.22	(0.79–1.91)	1.67^a	(1.02–2.83)^a
Bladder exstrophy	3.24	(0.95–20.28)	3.46	(0.97–22.16)
Cloacal malformation	1.09	(0.71–1.70)	1.84^a	(1.04–3.42)^a
Spinal cord injury	0.98	(0.38–3.06)	2.95	(1.09–10.3)
Eagle-Barrett syndrome	1.61	(0.45–10.28)	^b	^b
Other	0.76^a	(0.59–0.98)^a	1.02	(0.77–1.35)
Presence of mitrofanoff	2.41^a	(1.81–3.24)^a	3.14^a	(2.19–4.63)^a
Presence of hydronephrosis	1.01	(0.51–2.21)	1.22	(0.51–3.42)
Presence of VUR	2.20^a	(1.63–3.24)^a	4.55^a	(3.07–6.98)^a